Speech-Language Pathologists in Shippenville, PA Accepting Medicare
5 Speech-Language Pathologists found. Showing 1 - 5
 Sandra Ellen Clark, MS CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 242 Maple Dr, Shippenville, PA 16254 Phone: 814-782-6342 |
Krista Weber, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 124 Sycamore Dr, Shippenville, PA 16254 Phone: 814-223-4649 |
Melissa Sue Pore, CCC/SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 21158 Paint Blvd, Shippenville, PA 16254 Phone: 814-227-9166 |
Mrs. Courtney Lyn Lewis, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 90 Bigley Rd, Shippenville, PA 16254 Phone: 724-747-3038 |
 Advanced Dysphagia Diagnostics Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 206 Main St, Shippenville, PA 16254 Phone: 909-213-5967 Fax: 509-356-4607 |
News Archive
Trial to investigate new therapies for sleep apnea
New trials at The University of Western Australia may offer hope to sufferers of sleep apnea who struggle to get a full night's sleep without disruption.
AGA Medical Holdings to offer 13,750,000 shares of common stock at $14.50 per share
AGA Medical Holdings, Inc. (the "Company") announced the pricing of its initial public offering of 13,750,000 shares of common stock at $14.50 per share. The Company expects to sell 6,509,000 shares, and 7,241,000 shares are expected to be sold by the selling stockholders. The offering is expected to close on October 26, 2009.
IMRT minimizes gastrointestinal side effects of prostate cancer treatment
Men with prostate cancer treated with a specialized type of radiation called intensity modulated radiation therapy (IMRT) have fewer gastrointestinal complications compared to patients treated with conventional three-dimensional conformal radiotherapy (3D-CRT), according to a study presented November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).
New study signals hope for treatment of rare neurodegenerative disease
A new study led by St. Jude Children's Research Hospital scientists signals hope for treatment of a neurodegenerative disease and a new model for understanding the mechanism at work in other more common neurodegenerative disorders.
› Verified 7 days ago
Speech-Language Pathologists
Chiropractors
Physical Therapists